BioNTech SE (BNTX) Liabilities and Shareholders Equity (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Liabilities and Shareholders Equity data on file, last reported at $25.6 billion in Q4 2025.

• For the quarter ending Q4 2025, Liabilities and Shareholders Equity rose 6.32% year-over-year to $25.6 billion; the trailing twelve-month figure through Dec 2025 stood at $97.3 billion (up 0.53% YoY), and the FY2025 full-year result was $24.8 billion, up 3.19% from the prior year.
• Liabilities and Shareholders Equity climbed to $25.6 billion in Q4 2025, from $24.9 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $25.6 billion in Q4 2025 to a low of $5.1 billion in Q1 2021.
• A 5-year average of $21.7 billion and a median of $23.8 billion in 2022 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity surged 927.56% in 2021 and dropped 7.85% in 2025, its largest moves.
• Tracing BNTX's Liabilities and Shareholders Equity over 5 years: stood at $18.1 billion in 2021, then jumped by 31.15% to $23.8 billion in 2022, then gained by 4.22% to $24.8 billion in 2023, then fell by 2.74% to $24.1 billion in 2024, then gained by 6.32% to $25.6 billion in 2025.
• Business Quant data shows BNTX's Liabilities and Shareholders Equity at $25.6 billion in Q4 2025, $24.9 billion in Q3 2025, and $24.5 billion in Q2 2025.